Addiction Treatment Centers

Gaudenzia Inc

Washington House

1516 Washington Avenue, Philadelphia, PA 19146

Gaudenzia Inc Washington House is a residential and sober living facility in Philadelphia, PA offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting Medicaid and Medicare.

Licenses and accreditations

  • Commission on Accreditation of Rehabilitation Facilities (CARF)Accredited by CARF, an independent nonprofit accreditor of health and human services.

Kinds of care

Substance use treatment
Treatment for alcohol and drug use.
Transitional housing, halfway house, or sober home
A drug- and alcohol-free place to live with support, often after treatment.

Settings

Long-term residential
Living at the facility for more than 30 days.
Residential/24-hour residential
Living at the facility during treatment.

Medications for opioid use

Buprenorphine used in Treatment
Buprenorphine is used here.
Naltrexone used in Treatment
Naltrexone is used here.
Accepts clients using MAT but prescribed elsewhere
Accepts clients whose medication for opioid use is prescribed elsewhere.
Buprenorphine maintenance
Buprenorphine continued over time to prevent relapse.
Lofexidine or Clonidine detoxification
Lofexidine or clonidine to ease withdrawal during detox.
Prescribes buprenorphine
Prescribes buprenorphine.

Payment

Accepted
Medicaid; Medicare.

Who they serve

Ages served
Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
Sex
Female.
Programs for
Adult women; Clients with co-occurring mental and substance use disorders.
More details this facility reports
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity.
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder.
External Source of Medications Used for Alcohol Use Disorder Treatment
Other contracted prescribing entity.
Pharmacotherapies
Buprenorphine with naloxone; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation.
Treatment Approaches
12-step facilitation; Anger management; Brief intervention; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling.
Facility Operation (e.g., Private, Public)
Private non-profit organization.
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening.
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
Recovery Support Services
Assistance with obtaining social services; Housing services; Mentoring/peer support; Self-help groups.
Education and Counseling Services
Group counseling; Individual counseling; Substance use disorder education.
Facility Smoking Policy
Smoking permitted in designated area.
Facility Vaping Policy
Vaping not permitted.

Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.